Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-04 4:39 pm Purchase | 2024-10-28 | 13D | Septerna, Inc. SEPN | RA CAPITAL MANAGEMENT L.P. | 6,995,858 15.800% | 6,995,858 (New Position) | Filing History |
| 2024-10-31 4:17 pm Purchase | 2024-10-24 | 13G | Monopar Therapeutics Inc. MNPR | RA CAPITAL MANAGEMENT L.P. | 511,207 9.700% | 511,207 (New Position) | Filing History |
| 2024-10-22 5:11 pm Sale | 2024-10-18 | 13D | Tyra Biosciences, Inc. TYRA | RA CAPITAL MANAGEMENT L.P. | 10,091,071 19.990% | -384,418 (-3.67%) | Filing History |
| 2024-10-22 4:17 pm Sale | 2024-10-18 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,443,181 19.990% | -299,812 (-2.79%) | Filing History |
| 2024-10-07 4:16 pm Purchase | 2024-09-27 | 13G | BioAge Labs, Inc. BIOA | RA CAPITAL MANAGEMENT L.P. | 2,210,589 6.200% | 2,210,589 (New Position) | Filing History |
| 2024-10-01 5:47 pm Purchase | 2024-09-27 | 13D | Wave Life Sciences Ltd. WVE | RA CAPITAL MANAGEMENT L.P. | 25,414,165 16.000% | 8,144,354 (+47.16%) | Filing History |
| 2024-09-23 4:17 pm Purchase | 2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX | RA CAPITAL MANAGEMENT L.P. | 6,955,993 12.800% | 6,955,993 (New Position) | Filing History |
| 2024-09-16 9:35 pm Purchase | 2024-09-12 | 13D | Janux Therapeutics, Inc. JANX | RA CAPITAL MANAGEMENT L.P. | 10,742,993 19.990% | 149,598 (+1.41%) | Filing History |
| 2024-09-16 8:21 pm Purchase | 2024-09-12 | 13G | Fulcrum Therapeutics, Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 10,229,099 19.300% | 4,684,883 (+84.50%) | Filing History |
| 2024-09-03 4:18 pm Unchanged | 2024-08-29 | 13D | Artiva Biotherapeutics, Inc. ARTV | RA CAPITAL MANAGEMENT L.P. | 9,853,302 40.600% | 0 (Unchanged) | Filing History |
| 2024-08-23 4:16 pm Purchase | 2024-08-13 | 13G | Avalo Therapeutics, Inc. AVTX | RA CAPITAL MANAGEMENT L.P. | 967,299 9.990% | 967,299 (New Position) | Filing History |
| 2024-08-23 4:16 pm Sale | 2024-08-21 | 13G | Fulcrum Therapeutics, Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 5,544,216 9.990% | -6,065,488 (-52.24%) | Filing History |
| 2024-08-13 5:40 pm Sale | 2024-08-09 | 13G | AN2 Therapeutics, Inc. ANTX | RA CAPITAL MANAGEMENT L.P. | 1,999,997 6.700% | -3,551,298 (-63.97%) | Filing History |
| 2024-08-12 4:22 pm Purchase | 2024-07-31 | 13G | Adagio Medical Holdings, Inc. ADGM | RA CAPITAL MANAGEMENT L.P. | 1,337,813 9.990% | 1,337,813 (New Position) | Filing History |
| 2024-08-07 5:51 pm Unchanged | 2024-08-05 | 13D | 89bio, Inc. ETNB | RA CAPITAL MANAGEMENT L.P. | 14,254,298 13.400% | 0 (Unchanged) | Filing History |
| 2024-07-29 4:29 pm Purchase | 2024-07-22 | 13D | Artiva Biotherapeutics, Inc. ARTV | RA CAPITAL MANAGEMENT L.P. | 9,853,302 42.300% | 9,853,302 (New Position) | Filing History |
| 2024-07-25 4:16 pm Purchase | 2024-07-18 | 13D | Cidara Therapeutics, Inc. CDTX | RA CAPITAL MANAGEMENT L.P. | 703,080 9.990% | 703,080 (New Position) | Filing History |
| 2024-07-08 4:17 pm Purchase | 2024-06-28 | 13G | Recursion Pharmaceuticals, Inc. RXRX | RA CAPITAL MANAGEMENT L.P. | 15,384,615 5.900% | 15,384,615 (New Position) | Filing History |
| 2024-07-01 9:31 pm Purchase | 2024-06-21 | 13G | Praxis Precision Medicines, Inc. PRAX | RA CAPITAL MANAGEMENT L.P. | 1,235,599 7.200% | 1,235,599 (New Position) | Filing History |
| 2024-07-01 9:28 pm Purchase | 2024-06-27 | 13D | Climb Bio, Inc. CLYM | RA CAPITAL MANAGEMENT L.P. | 31,459,267 47.100% | 18,268,418 (+138.49%) | Filing History |